[1]张 瑞,柳围堤,程自超,等.恒古骨伤愈合剂对人骨髓间充质干细胞生长、分化的影响及机制研究[J].陕西医学杂志,2021,50(12):1477-1481,1486.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.003]
 ZHANG Rui,LIU Weidi,CHENG Zichao,et al.Effect and mechanism of Osteoking on growth and differentiation of human bone mesenchymal stem cells[J].,2021,50(12):1477-1481,1486.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.003]
点击复制

恒古骨伤愈合剂对人骨髓间充质干细胞生长、分化的影响及机制研究
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
50
期数:
2021年12期
页码:
1477-1481,1486
栏目:
基础研究
出版日期:
2021-12-05

文章信息/Info

Title:
Effect and mechanism of Osteoking on growth and differentiation of human bone mesenchymal stem cells
作者:
张 瑞柳围堤程自超杜怀峰
(西安交通大学医学院附属3201医院康复医学科,陕西 汉中 723000)
Author(s):
ZHANG RuiLIU WeidiCHENG ZichaoDU Huaifeng
(Department of Rehabilitation Medicine,3201 Hospital,School of Medicine,Xi'an Jiaotong University,Hanzhong 723000,China)
关键词:
恒古骨伤愈合剂 人骨髓间充质干细胞 细胞增殖活性 细胞分化 TGF-β1/Smads信号通路
Keywords:
Osteoking Human bone marrow mesenchymal stem cells Cell proliferation activity Cell differentiation TGF-β1/Smads signaling pathway
分类号:
R 285.5
DOI:
DOI:10.3969/j.issn.1000-7377.2021.12.003
文献标志码:
A
摘要:
目的:探讨恒古骨伤愈合剂对人骨髓间充质干细胞(hBMSCs)生长、分化的影响及机制。方法:全骨髓贴壁法培养hBMSCs,取第3代以含恒古骨伤愈合剂血清培养基培养(研究组),并以完全培养基为对照组。观察两组hBMSCs形态和碱性磷酸酶(ALP)染色结果。采用四氮唑盐比色法(MTT)检测两组hBMSCs细胞增殖活性。采用实时荧光定量PCR(RT-PCR)测定两组成骨分化特异性标志物转化生长因子-β1(TGF-β1)、人Ⅰ型胶原(Col Ⅰ)、骨钙素(OCN),破骨分化标志物核因子-κB活化因子受体配体(RANKL),破骨细胞抑制因子(OPG)相对表达量。采用Western blot检测Smad2/3蛋白表达。结果:研究组培养48 h后细胞形态逐渐变为圆形、多边形,细胞界限模糊,呈现聚集特点,类似成骨细胞形态,可见数量不均微小颗粒物质,部分见发育成熟矿化物; 对照组培养48 h后细胞形态呈梭形,突起变长,分散生长,细胞两极朝向不规律,可见少量微小颗粒物质。研究组hBMSCs含药血清培养1周后ALP染色程度高、显色范围广,对照组ALP着色弱、强度低,表明研究组hBMSCs分化潜能高。研究组hBMSCs培养不同时间增殖活性高于对照组(均P<0.05)。研究组hBMSCs培养1周TGF-β1、Col Ⅰ、OCN、OPG mRNA相对表达量高于对照组,RANKL mRNA相对表达量低于对照组(均P<0.05)。研究组hBMSCs培养1周p-Smad2/3蛋白相对表达量高于对照组(均P<0.05)。结论:恒古骨伤愈合剂可上调TGF-β1/Smads信号通路相关促骨形成靶基因表达,促进骨形成,抑制骨吸收,进而促进hBMSCs生长及分化。
Abstract:
Objective:To investigate the effect and mechanism of Osteoking on the growth and differentiation of human bone marrow mesenchymal stem cells(hBMSCs).Methods:The hBMSCs were cultured by whole bone marrow adherence method.The third generation of hBMSCs were cultured in serum medium containing Osteoking(study group),and the complete medium was used as the control group.The cell morphology and alkaline phosphatase(ALP)staining results of the two groups of hBMSCs were observed.The proliferation activity of the two groups of hBMSCs was detected by MTT.The expression of specific markers of osteogenic differentiation transforming growth factor-β1(TGF-β1),human type Ⅰ collagen(Col Ⅰ)and osteocalcin(OCN),markers of osteoclast differentiation the ligand for receptor activator of nuclear factor-κB(RANKL)and osteoclast inhibitor(OPG)in each group was determined by RT-PCR.The expression of Smad2/3 proteins were detected by Western blot.Results:After 48 hours of culture in the study group,the morphology of the cells gradually became round and polygonal,and the cell boundaries were blurred,showing the characteristics of aggregation,similar to the shape of osteoblasts,with uneven amounts of small particulate matter and some mature minerals; after 48 hours of culture in the control group,the cell morphology was fusiform and the protrusions was elongated,the growth was scattered,the cell poles were oriented irregularly,and a small amount of small particulate matter could be seen. The hBMSCs-containing serum of the study group was cultured for 1 week with high degree of ALP staining and a wide range of color development,while the control group had weak ALP staining and low intensity,indicating that the study group had a high differentiation potential for hBMSCs.The proliferation activities of hBMSCs in study group were higher than those in the control group after different time of culture(all P<0.05).The relative expression levels of TGF-β1,ColⅠ,OCN and OPG mRNA in hBMSCs in study group were higher than those in the control group after 1 week of culture,and the relative expression level of RANKL mRNA was lower than that in the control group(all P<0.05).The expression levels of p-Smad2/3 proteins in study group were higher than those in the control group after 1 week of culture(all P<0.05).Conclusion:Osteoking can up-regulate the expression of TGF-β1/Smads signaling pathway associated osteotropic formation target genes,promote bone formation,inhibit bone resorption,and promote the growth and differentiation of hBMSCs.

参考文献/References:

[1] 黄 震,王开明,廖 亮,等.经皮椎体后凸成形术与经皮椎体成形术治疗骨质疏松性椎体压缩骨折的疗效及并发症对比分析[J].陕西医学杂志,2018,47(4):491-493.
[2] 尹素娟,张荣华,朱晓峰,等.rhTGF-β1对SD大鼠MSCs骨向分化的影响及机制研究[J].中国病理生理杂志,2014,30(3):460-466.
[3] Wu N,Ge Y,Zhou Y,et al.Nanosized titanium dioxide resulted in the activation of TGF-β/Smads/p38 MAPK pathway in renal inflammation and fibration of mice[J].J Biomed Mater Res A,2016,104(6):1452-1461.
[4] 马江卫,贾爱华,刘新艳,等.唑来膦酸联合经皮椎体后凸成形术治疗骨质疏松椎体压缩性骨折临床疗效观察[J].陕西医学杂志,2019,48(3):358-361.
[5] Yan XH,Liao HW,Cheng MZ,et al.Smad7 protein interacts with receptor-regulated Smads(R-Smads)to inhibit transforming growth factor-β(TGF-β)/Smad signaling[J].J Biol Chem,2016,291(1):382-392.
[6] 角建林,唐 薇,郑 红,等.彝药恒古骨伤愈合剂缓解去势树鼩骨质疏松症[J].基础医学与临床,2018,38(12):1686-1690.
[7] 郑 红,赵宏斌,袁 鑫,等.恒古骨伤愈合剂通过PI3K/AKT/GSK-3β信号通路治疗树鼩绝经后骨质疏松的作用机制[J].中国老年学杂志,2019,34(3):626-630.
[8] 张慧杰,王小琦,孙 岩,等.恒古骨伤愈合剂初步分离及其促骨形成活性的评价[J].中华中医药杂志,2018,33(4):1512-1515.
[9] 张建康,卫俊俊,唐曌隆,等.Wnt和Notch通路在老龄个体骨髓间充质干细胞成骨中的调控[J].国际口腔医学杂志,2017,44(4):459-465.
[10] 黄光明.理中汤加减治疗慢性心力衰竭及对患者血清BNP、IL-10 及NOS水平的影响研究[J].陕西中医,2021,42(2):159-162.
[11] 苏冬娜,吴诗品.Smad7基因质粒转染骨髓间充质干细胞在体外对肝星状细胞 TGF-β1信号传导的影响[J].中国免疫学杂志,2016,32(10):1441-1445.
[12] Mi W,Shi Q,Chen X,et al.MiR-33a-5p modulates TNF-α-inhibited osteogenic differentiation by targeting SATB2 expression in hBMSCs[J].Febs Lett,2016,590(3):396-407.
[13] Wang H,Li C,Li J,et al.Naringin enhances osteogenic differentiation through the activation of ERK signaling in human bone marrow mesenchymal stem cells[J].Iran J Basic Med Sci,2017,20(4):408-414.
[14] 李 雪,申意伟,张晓峰,等.从“血瘀”论治骨质疏松症之古代方药研究[J].中医药学报,2019,47(1):11-14.
[15] 李建国,谢兴文,李鼎鹏,等.淫羊藿提取物淫羊藿苷在细胞水平防治骨质疏松症的研究概况[J].中国骨质疏松杂志,2019,25(1):132-135.
[16] 李三华,陈全利,杨加强.杜仲总黄酮对去卵巢大鼠骨组织代谢的影响[J].中国老年学杂志,2018,38(13):3198-3200.
[17] 谭铭辉,梁宇灵,黄文斌,等.Galectin-3诱导大鼠骨髓间充质干细胞分化为肝样细胞[J].南方医科大学学报,2018,38(9):1076-1082.
[18] Han HS,Ju F,Geng S.In vivo and in vitro effects of PTH1-34 on osteogenic and adipogenic differentiation of human bone marrow-derived mesenchymal stem cells through regulating microRNA-155[J].J Cell Biochem,2017,119(4):3220-3235.
[19] 王 磊,白艳辉,王 兰,等.骨髓间充质干细胞对大鼠急性肺损伤时TGF-β1/Smad信号通路的影响[J].中华麻醉学杂志,2019,39(1):105-108.
[20] Lu BW,Liu N,Xu LL,et al.Difference of in vitro osteogenic differentiation and osteoclast capacity between stem cells from human exfoliated deciduous teeth and dental pulp stem cells[J].J South Med Univ,2016,36(2):180-185.
[21] 何 霞,崔 璨,陈 敏.骨髓间充质干细胞移植对实验性大鼠缺血性脑梗死免疫炎性反应的影响研究[J].中国免疫学杂志,2018,34(5):647-652.
[22] Wang Y,Wu H,Shen M,et al.Role of human amnion-derived mesenchymal stem cells in promoting osteogenic differentiation by influencing p38 MAPK signaling in lipopolysaccharide-induced human bone marrow mesenchymal stem cells[J].Exp Cell Res,2017,350(1):41-49.
[23] Zhang J,Tao Z,Wang Y.Long non-coding RNA DANCR regulates the proliferation and osteogenic differentiation of human bone-derived marrow mesenchymal stem cells via the p38 MAPK pathway[J].Int J Mol Med,2018,41(1):213-219.
[24] 刘登榜,韩小松,黄文良,等.TGF-β3诱导大鼠骨髓间充质干细胞成软骨细胞分化的实验观察[J].中华医学杂志,2017,97(36):2860-2865.
[25] Zhang GP,Zhang J,Zhu CH,et al.MicroRNA-98 regulates osteogenic differentiation of human bone mesenchymal stromal cells by targeting BMP2[J].J Cell Mol Med,2017,21(2):254-264.
[26] Gao Y,Xiao F,Wang C,et al.Long noncoding RNA MALAT1 promotes osterix expression to regulate osteogenic differentiation by targeting miRNA-143 in human bone marrow-derived mesenchymal stem cells[J].J Cell Biochem,2018,119(8):6986-6996.
[27] 代光明,任 磊,陈 虹,等.下调骨细胞TGF-β/Smad4信号可抑制小鼠BMSCs成骨及破骨分化[J].基础医学与临床,2017,37(6):786-791.

备注/Memo

备注/Memo:
基金项目:国家中医药管理局中医药科学技术研究专项课题(CZY-KJS-2021-003)
更新日期/Last Update: 2021-12-07